Company Overview and News
NextEra Energy, Inc. (NEE - Free Report) is expected to beat earnings when it reports second-quarter 2018 results, which is slated to be announced on July 25 before the opening bell. Last quarter, this utility reported a positive earnings surprise of 8.99%. Why a Likely Positive Surprise? Our proven model shows that NextEra Energy is likely to beat on earnings because it has the right combination of two key ingredients.
NEE.PRI NEE.PRJ AEP.PRA ES KDP NEE.PRC NEE.PRQ AEP NEE.PRR NEE
Duke Energy’s (DUK - Free Report) subsidiary — Duke Energy Carolinas — applied for new rates to the North Carolina Utilities Commission (“NCUC”). The company will pass the savings from recent federal tax reform to all customers groups. The new electric rates will be phased out over the next four years and will decline by average 1.34% post NCUC’s approval and adjust to a 0.22% fall in August 2022 However, residential customers will experience a marginal increase in utility bills.
WFCNP SOJA WFC.PRL WFC.PRJ WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN AGR WFC.PRY WFC.PRX WFC.PRW NEE WFC.PRV WFC WFC.WS SO DUKH UNP DUK NEE.PRI NEE.PRJ NEE.PRC NEE.PRQ NEE.PRR
Alliant Energy (LNT - Free Report) announced its plans to produce more wind energy from Iowa and entered into an agreement with Invenergy for development of the 210-megawatt (MW) Richland Wind Farm in Sac County, IA. Per the agreement, it will construct as well as own the wind farm. Richland Wind Farm is part of Alliant Energy's plan to add 1,000 MW of new wind generation for Iowa customers by the end of 2020 to provide enough power to 430,000 homes.
NEE.PRI DUKH NEE.PRJ LNT NEE.PRC NEE.PRQ NEE.PRR DUK NEE AQN
Here's one from the Wonders Never Cease Dept.: When I say the Dividend Growth 50 has been "kindered," this time, it's actually a good thing!
GIS CAT XOM KMI.WS WMT COP NEE.PRI NEE.PRJ TGT V KMI.PRA KMI JNJ NEE.PRC AAPL NEE.PRQ NEE.PRR SBUX KMR CVB KMRFZ MCD NEE
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
KMI.WS ECOR PLNT KMI.PRA PKG AEP NINE ADT GE COF-P GILD TMUS PDYPF SYF XERS JNJ VZ MSFT ADS KZR NNN EIDX FB RF.PRB AVRO RF.PRA HOPE NFLX AXP EHC BAC COF-D SEAS COF-C COF-F KR KS IIIV PNFP AAPL DDOC AEP.PRA SJM INPAP SIX JPM GNE WRK LGEJY KMRFZ DE 39IB KMX COF.WS RF UAL WMT CFIN LGEAF IP AMZN MGTA NTRS HON KMI CIWV GM.WS.A GM.WS.B HCSG GM.WS.C KMR CVB VLKAY LGEIY EBAY EPRT STT SLB BAC DFS LGEPF STM BBY BX BK STM LTXB LGLD SLB GM.WSB FOXA CLW COF.PRG COF.PRH PM STT.PRC STT.PRE NTRSP STT.PRD STT.PRG AUTL COF.PRP DLPH SWKS GS SWK TRTX GM PII COF.PRC COF.PRD DIS NEE COF.PRF IBM MOR F GEC C CMCSA COF FUN FUL CFG HBAN NEE.PRI XEL NEE.PRJ TGT BLK S PPG T NEE.PRC NEE.PRQ NEE.PRR SNE DPZ
Cigna Corporation: “OK, when [CEO] David Cordani came on, the stock was right around here. I continue to believe it deserves to be much higher. They’re doing an acquisition with Express Scripts. The stock is undervalued."
NEE.PRI NEE.PRJ LRCX WST NEE.PRC WWE NEE.PRQ NEE.PRR CI NEE
Stocks continue to get more expensive despite the trade war headwinds investors face in the weeks ahead. S&P 500 stocks currently trade at 24 times trailing earnings and 17 times forward earnings making the selection of new additions to a portfolio that much more difficult.
WDC GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG CVS MS.PRA NRGEO NWL GS GLSSP AMZN CAH MS NEE JBK GSC GS.PRICL TFG NYTAB CMI GSJ NEE.PRI GS.PRJ NRG NEE.PRJ GS.PRI MS.PRI MU NEE.PRC GS.PRD MS.PRK GS.PRC NEE.PRQ NEE.PRR GJS GS.PRN GS.PRK
It’s a question that has nagged at investors for as long as both asset categories have existed … are stocks the way to go, or bonds? If both, how much of either belong in a portfolio?
NEE.PRI NEE.PRJ NEE.PRC NEE.PRQ NEE.PRR WMT NEE
Brookfield Infrastructure Partners has crushed most other utilities and the S&P 500 over the past decade.
BAMGF ENBBF ENB 532712 NEE.PRI ENB BRK.A NEE.PRJ RCOM NEE.PRC NEE.PRQ NEE.PRR EBBNF BIP BAMKF BAM NEE
JinkoSolar Holding Company Ltd. (JKS - Free Report) recently announced that will supply 86 megawatt (MW) of solar modules to Colombia’s largest Photovoltaic (PV) Plant. Per the terms of the deal, Jinko Solar’s 250,000 Monocrystalline Standard Modules with the capacity of 345 Watt – 1500 V will generate 176 Gigawatt hours (GWh) of clean energy on average every year. JinkoSolar as a Global Solar Module Supplier China-based JinkoSolar offers solar modules, solar system integration services and photovoltaic products in the global market.
NEE.PRI NEE.PRJ NEE.PRC NEE.PRQ SEDG NEE.PRR AES.PRC AES NEE
Xcel Energy (XEL - Free Report) purchased a wind project named Hale Wind Project in Texas from NextEra Energy Resources — a subsidiary of NextEra Energy (NEE - Free Report) . The construction of the 478-megawatt (MW) wind project will need nearly $735 million. Meanwhile, the terms of the deal have not been disclosed. Construction work is expected to start this month, subject to approval from regulators of Texas and New Mexico.
NRGEO NEE.PRI NRG XEL NEE.PRJ NEE.PRC NEE.PRQ NEE.PRR NEE
American Water Works Company (AWK - Free Report) announced that its subsidiary, Pennsylvania American Water has received directive from the Pennsylvania Public Utility Commission (PUC) to pass on the tax savings benefits resulting from the implementation of the Tax Cuts and Jobs Act (TCJA) to customers. The new act became effective Jan 1, 2018 and lowered the corporate tax rate from 35% to 21%. This move will lead to reduction of about $47 million annually in the federal income tax that Pennsylvania American Water will pay to the government.
DUKH BLT BHPBF DUK NEE.PRI NEE.PRJ BHP NEE.PRC NEE.PRQ BBL NEE.PRR GWRS BHP BHPLF NEE
Duke Energy (NYSE:DUK) will pass on an amount of $142 million in annual tax savings to the electric bills of its Indiana-based customers, if the proposed settlement with consumer groups is approved by Indiana Utility Regulatory Commission.
NEE.PRI DUKH NEE.PRJ NEE.PRC WGL NEE.PRQ AGR NEE.PRR DUK NEE
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to NEE / NextEra Energy, Inc. on message board site Silicon Investor.
as of ET